BERLIN (AP) — Swiss pharmaceutical company Novartis says its net profit rose 10 percent in the second quarter, helped by gains from divestments.
Novartis said Tuesday that net earnings rose to $1.98 billion in the April-June period from $1.81 billion a year earlier.
Net sales, however, were down 2 percent, slipping to $12.24 billion from $12.47 billion. While sales grew in terms of volume, Novartis said that revenue took a hit from generic competition and pricing.
The Basel-based company reaffirmed its full-year outlook for net sales is broadly in line with last year’s and core operating income also remaining steady or declining by a “low single-digit” percentage.
Most Read Stories
- A Washington syrah was named second best wine in the world
- Expect record-high temps, 'copious rain' in Seattle area as we head toward Thanksgiving VIEW
- Retired Alabama cop on Roy Moore: ‘We were also told to ... make sure that he didn’t hang around the cheerleaders’
- Fake field goal? An errant challenge? Blame Pete Carroll for Seahawks' loss to Atlanta
- Bicyclist dies in hit-and-run crash in Sodo, police say
For the year’s first half, net profit was off 5 percent at $3.64 billion and sales slipped 1 percent to $23.78 billion.